MANAGEMENT AND OPERATIVE TEAM
Stefan Johansson, CEO, is a Consultant Neonatologist and Associate Professor, and holds a PhD in epidemiology and biostatistics at Karolinska Institutet. In addition to be a social entrepreneur, being founder of 99nicu.org and ebneo.org, he has vast knowledge in research design and works in several large-scale projects. With his methodological expertise, Stefan Johansson has published on a large variety of research topics, including very preterm birth, maternal obesity, patent ductus arteriosus, neonatal jaundice, Down syndrome and birth asphyxia.
Philipp Novak, COO, holds a doctorate in veterinary medicine and an MSc in pharmaceutical medicine, and has more than 14 years of industry experience, involving global roles in Research & Development and Innovation. Philipp Novak is also CEO and founder of orphanix GmbH, a development firm for medical treatments of rare and neglected diseases.
Natasha Olsson, Marketing Manager, holds a BSc in Business and Economics from Stockholm School of Economics. She has previously worked as a Project Manager within health care policy research and with marketing in the pharmaceutical industry. She has a broad international exposure, e.g., from studying in France and the Democratic Republic of Congo.
Vera Westin, Customer Support Manager, is dietitian and was employed at the Karolinska University Hospital between 1980 and 2018. She holds a PhD in neonatal nutrition at Karolinska Institutet. During the last two decades of her professional career, the clinical focus was on preterm infants’ nutrition and growth. As lead dietitian she had an important role regarding mind setting/know how of colleagues working at neonatal units locally as well as nationally.
SCIENTIFIC ADVISORY BOARD
Nicholas Embleton is a Consultant Neonatologist (appointed 2003) and Honorary Reader at Newcastle University, UK. His MD research was on protein requirements in preterm infants (awarded 2002). Since then he has developed a wide research portfolio including large interventional studies funded by the NIHR, mechanistic studies of gut microbes and NEC, lactoferrin and perinatal infections.Nicholas Embleton is a member of the Committee of Nutrition, ESPGHAN. He also has extensive experience of qualitative studies with parents of preterm infants who did not survive. His research group website is www.neonatalresearch.net.
Janet Berrington is a consultant neonatal paediatrician and senior lecturer in Newcastle, UK. Her MD research was on neonatal immunology and she has ongoing research in the microbiome, NEC and infection, which include clinical and translational elements. Janet Berrington is manager of the Great North Neonatal Biobank, a co-app in the EME funded mechanistic microbiomic and metabolomic study (MAGPIE, Mechanisms Affecting the Gut of Preterm Infants in Enteral feeding trials), and a member of the UK Neonatal Nutrition Network.
Per Torp Sangild is a Professor in Comparative Pediatrics and Nutrition at University of Copenhagen, Denmark and holds part-time appointments at Copenhagen and Odense University Hospitals. His degrees are PhD (1990), DVSc (1996) and DMSc (2010), all from University of Copenhagen. Research focus is on clinical nutrition and developmental gastroenterology with long experience in using animal (piglet) models for infants, particularly preterm infants. He is leading an international research network, NEOMUNE/NEOCOL, investigating milk and microbiota effects on immunity, gut and brain development (Danish Research Council, 2013-2021, www.neomune.ku.dk). International experience from longer research stays in United Kingdom, Australia and China. 170 peer-review publications.
Francesco Cardona is a Consultant Neonatologist at the Medical University Vienna, Austria. He has a Masters Degree in Epidemiology. His previous research was at the Department of Clinical Pharmacology conducting interventional studies. Currently he is doing research on the Austrian birth registry. Francesco Cardona is also an administrator of the 99nicu.org community, project-leading the annual conference Future of Neonatal Care, AKA as the #99nicuMeetup.
Marijn J. Vermeulen is a Consultant Neonatologist, at Erasmus University Medical Center in The Netherlands, since 2008. Her clinical focus is on nutrition and growth after preterm birth with a special interest in necrotizing enterocolitis. She is actively involved in the national neonatal parent advocacy organisation. As a senior researcher and clinical epidemiologist, she runs clinical studies (mainly in premature infants) and population based studies (embedded in Generation R and Generation R Next), on fetal and neonatal growth and the role of nutrition (including breast feeding, iron status) and circadian rhythm.
Bernd Kuntscher has a BSc in Business Administration and Economics from the Stockholm School of Economics. He has 28 years of experience in marketing and sales, market research and general management from the pharmaceutical and medical device industry. Bernd Kuntscher has worked at big pharmaceutical companies such as AstraZeneca and small, very specialised, companies such as Recordati Rare Diseases (previously Orphan Europe) where he is working now as General Manager for the Nordics & Baltics. He has experience from many different therapeutic areas, incuding rare metabolic diseases.
Gustav Johansson, CFO, holds a Bsc of business and economics, focused on accounting and finance, from Stockholm School of Economics. His analytic experience includes internships at Goldman Sachs (London office) and Altor (Stockholm office).
Kristina Magnusson Borg